Trial
NCT04491526
Study to Prevent Postoperative Urinary Retention
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Antonio Nocito, MD
Collaborators
—
Condition
Urinary Retention
Intervention
TAMSULOSIN Mepha Ret Depocaps 0.4 mg
Why stopped
The study was terminated prematurely following a pre-planned interim analysis demonstrating futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-17